Literature DB >> 5765763

Microbodies in experimentally altered cells. II. The relationship of microbody proliferation to endocrine glands.

D Svoboda, D Azarnoff, J Reddy.   

Abstract

The liver cells of intact male rats given ethyl-alpha-p-chlorophenoxyisobutyrate (CPIB) characteristically show a marked increase in microbodies and in catalase activity, while those of intact female rats do not. In castrated males given estradiol benzoate and CPIB the increase in catalase activity and microbody proliferation is abolished, while in castrated females given testosterone propionate and CPIB the livers show a marked increase in microbodies and in catalase activity. No sex difference in microbody and catalase response is apparent in fetal and neonatal rats. Both sexes show a sharp rise in catalase activity on the day of birth, with a rapid decline at 5 days after birth. Thyroidectomy abolishes the hypolipidemic effect of CPIB in rats, but microbody proliferation and increase in catalase activity persists in thyroidectomized male rats, indicating that microbody proliferation can be independent of hypolipidemia. Adrenalectomy does not alter appreciably the microbody-catalase response to CPIB. These experiments demonstrate that (1) in adult rats, hepatic microbody proliferation is dependent to a significant degree upon male sex hormone but is largely independent of thyroid or adrenal gland hormones; (2) hepatic microbody proliferation is independent of the hypolipidemic effect of CPIB; (3) displacement of thyroxine from serum protein may not be sufficient cause for stimulation of microbody formation.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5765763      PMCID: PMC2107643          DOI: 10.1083/jcb.40.3.734

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  34 in total

1.  Endoplasmic reticulum and the origin of microbodies in fetal mouse liver.

Authors:  E Essner
Journal:  Lab Invest       Date:  1967-07       Impact factor: 5.662

2.  Sex differences in the effects of abnormal physiological states on the metabolism of drugs by rat liver microsomes.

Authors:  R Kato; J R Gillette
Journal:  J Pharmacol Exp Ther       Date:  1965-11       Impact factor: 4.030

3.  Changes in the weight and composition of the liver in the rat, dog and monkey treated with ethyl chlorophenoxyisobutyrate.

Authors:  D S Platt; J M Thorp
Journal:  Biochem Pharmacol       Date:  1966-07       Impact factor: 5.858

4.  The effect of chlorphenoxyisobutyrate ('Atromid-S') on the biliary excretion and distribution of thyroxine in the rat.

Authors:  C Osorio; K W Walton; C H Browne; D West; P Whystock
Journal:  Biochem Pharmacol       Date:  1965-10       Impact factor: 5.858

Review 5.  Peroxisomes (microbodies and related particles).

Authors:  C De Duve; P Baudhuin
Journal:  Physiol Rev       Date:  1966-04       Impact factor: 37.312

6.  The effect of DDD on barbiturate and steroid-induced hypnosis in the dog and rat.

Authors:  D L Azarnoff; H J Grady; D J Svoboda
Journal:  Biochem Pharmacol       Date:  1966-12       Impact factor: 5.858

7.  Comparison of the effects of several drugs on tissue uptake of labeled thyroxine and triiodothyronine in the presence of rat plasma in vitro.

Authors:  Y Takemura; T Yamada; K Ozawa; K Shichijo
Journal:  Metabolism       Date:  1966-08       Impact factor: 8.694

8.  The effects of chronic protein deficiency in rats. II. Biochemical and ultrastructural changes.

Authors:  D Svoboda; H Grady; J Higginson
Journal:  Lab Invest       Date:  1966-04       Impact factor: 5.662

9.  The relationship between the structure and activity of rat skeletal muscle mitochondria after thyroidectomy and thyroid hormone treatment.

Authors:  R Gustafsson; J R Tata; O Lindberg; L Ernster
Journal:  J Cell Biol       Date:  1965-08       Impact factor: 10.539

10.  Response of hepatic microbodies to a hypolipidemic agent, ethyl chlorophenoxyisobutyrate (CPIB).

Authors:  D J Svoboda; D L Azarnoff
Journal:  J Cell Biol       Date:  1966-08       Impact factor: 10.539

View more
  21 in total

1.  Peroxisome proliferators and peroxisome proliferator-activated receptor alpha: biotic and xenobiotic sensing.

Authors:  Janardan K Reddy
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

2.  Effect of clofibrate application on morphology and enzyme content of liver peroxisomes.

Authors:  H Goldenberg; M Hüttinger; P Kampfer; R Kramar; M Pavelka
Journal:  Histochemistry       Date:  1976-02-26

3.  Sex-related difference in the inductions by perfluoro-octanoic acid of peroxisomal beta-oxidation, microsomal 1-acylglycerophosphocholine acyltransferase and cytosolic long-chain acyl-CoA hydrolase in rat liver.

Authors:  Y Kawashima; N Uy-Yu; H Kozuka
Journal:  Biochem J       Date:  1989-07-15       Impact factor: 3.857

4.  Sex-related differences in the enhancing effects of perfluoro-octanoic acid on stearoyl-CoA desaturase and its influence on the acyl composition of phospholipid in rat liver. Comparison with clofibric acid and tiadenol.

Authors:  Y Kawashima; N Uy-Yu; H Kozuka
Journal:  Biochem J       Date:  1989-11-01       Impact factor: 3.857

5.  Proliferation of microbodies and synthesis of catalase in rat liver. Induction in tumor-bearing host by CPIB.

Authors:  J Reddy; D Svoboda
Journal:  Am J Pathol       Date:  1971-04       Impact factor: 4.307

6.  Effects of catalase inhibitors on the ultrastructure and peroxidase activity of proliferating microbodies.

Authors:  P G Legg; R L Wood
Journal:  Histochemie       Date:  1970

7.  Ethyl- -p-chlorophenoxyisobutyrate induced hepatic microbody proliferation in rat liver and ubiquinone concentration.

Authors:  J Reddy; D Svoboda
Journal:  Experientia       Date:  1971-09-15

8.  Microbodies in experimentally altered cells. V. Histochemical and cytochemical studies on the livers of rats and acatalasemic (Csb) mice treated with CPIB.

Authors:  J Reddy; S Bunyaratvej; D Svoboda
Journal:  Am J Pathol       Date:  1969-09       Impact factor: 4.307

9.  Hepatic microbody proliferation and catalase synthesis induced by methyl clofenapate, a hypolipidemic analog of CPIB.

Authors:  J K Reddy
Journal:  Am J Pathol       Date:  1974-04       Impact factor: 4.307

10.  Prevention of CeCl3-induced hepatotoxicity by hypolipidemic compounds.

Authors:  B Tuchweber; M Salas
Journal:  Arch Toxicol       Date:  1978-12-28       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.